Over the past 12 months, 4 insiders at agilon health, inc. filed 5 open-market SEC Form 4 transactions on AGL: 5 purchases worth $351K and 0 sales worth $0. Insiders have been net buyers over this period. The most recent filing was on Mar 9, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 9, 26 | Benjamin ShakerChief Markets Officer | BUY | 18.4K | - | $0 |
| Mar 9, 26 | Girish VenkatachaliahChief Technology Officer | BUY | 18.4K | - | $0 |
| Mar 9, 26 | Denise ZamoreChief Legal Officer | BUY | 5.5K | - | $0 |
| Mar 2, 26 | Benjamin ShakerChief Markets Officer | BUY | 500.0K | $0.60 | $300K |
| Nov 12, 25 | John William WulfDirector | BUY | 81.0K | $0.63 | $51K |
| Mar 14, 25 | Steven SellCEO & President | BUY | 42.4K | - | $0 |
| Mar 14, 25 | Benjamin ShakerChief Markets Officer | BUY | 11.8K | - | $0 |
| Mar 14, 25 | Girish VenkatachaliahChief Technology Officer | BUY | 9.4K | - | $0 |
| Dec 13, 24 | Karen McLoughlinDirector | BUY | 25.0K | $2.20 | $55K |
| Dec 11, 24 | Silvana BattagliaDirector | BUY | 25.1K | $2.01 | $50K |
| Dec 9, 24 | Diana McKenzieDirector | BUY | 7.5K | $2.20 | $17K |
| Dec 5, 24 | John William WulfDirector | BUY | 45.0K | $2.18 | $98K |
| Nov 25, 24 | Diana McKenzieDirector | BUY | 12.5K | $2.28 | $29K |
| Sep 12, 24 | Steven SellCEO & President | BUY | 20.0K | $3.36 | $67K |
| Mar 14, 24 | Timothy BensleyChief Financial Officer | BUY | 14.9K | - | $0 |
| Mar 14, 24 | Veeral DesaiChief Strategy & Dev. Officer | BUY | 12.0K | - | $0 |
| Mar 14, 24 | Benjamin KornitzerChief Med. & Quality Officer | BUY | 5.4K | - | $0 |
| Mar 14, 24 | Benjamin ShakerChief Markets Officer | BUY | 274.5K | - | $0 |
| Mar 14, 24 | Girish VenkatachaliahChief Technology Officer | BUY | 5.4K | - | $0 |
| Nov 29, 23 | Jeffrey A. SchwanekeChief Financial Officer | BUY | 22.3K | $11.22 | $250K |
| Nov 21, 23 | Steven SellCEO & President | BUY | 44.7K | $11.14 | $498K |
| Sep 13, 23 | Benjamin ShakerChief Markets Officer | SELL | 18.8K | $18.00 | $338K |
| Sep 12, 23 | Benjamin ShakerChief Markets Officer | SELL | 18.8K | $18.05 | $338K |
| Sep 11, 23 | Timothy GertschChief Accounting Officer | SELL | 17.5K | $18.62 | $326K |
| Aug 15, 23 | Benjamin ShakerChief Markets Officer | SELL | 18.8K | $18.10 | $339K |
| Aug 14, 23 | Benjamin ShakerChief Markets Officer | SELL | 18.8K | $18.72 | $351K |
| Jul 13, 23 | Benjamin ShakerChief Markets Officer | SELL | 18.8K | $16.93 | $317K |
| Jul 12, 23 | Benjamin ShakerChief Markets Officer | SELL | 18.8K | $16.97 | $318K |
| Jun 15, 23 | Benjamin ShakerChief Markets Officer | SELL | 18.8K | $18.73 | $351K |
| Jun 14, 23 | Benjamin ShakerChief Markets Officer | SELL | 15.8K | $19.17 | $294K |
| May 16, 23 | Benjamin ShakerChief Markets Officer | SELL | 25.0K | $23.14 | $579K |
| May 15, 23 | Benjamin ShakerChief Markets Officer | SELL | 25.0K | $23.79 | $595K |
| May 9, 23 | Veeral DesaiChief Strategy & Dev. Officer | SELL | 4.5K | $26.15 | $118K |
| Apr 20, 23 | Veeral DesaiChief Strategy & Dev. Officer | SELL | 500 | $26.15 | $13K |
| Apr 19, 23 | Veeral DesaiChief Strategy & Dev. Officer | SELL | 4.5K | $27.84 | $122K |
| Apr 18, 23 | Benjamin ShakerChief Markets Officer | SELL | 25.0K | $28.05 | $701K |
| Apr 17, 23 | Benjamin ShakerChief Markets Officer | SELL | 23.6K | $28.54 | $654K |
| Mar 24, 23 | Veeral DesaiChief Strategy & Dev. Officer | SELL | 97.3K | $28.70 | $2.8M |
| Mar 23, 23 | Veeral DesaiChief Strategy & Dev. Officer | SELL | 22.7K | $28.71 | $652K |
| Mar 23, 23 | Benjamin KornitzerChief Med. & Quality Officer | SELL | 8.1K | $28.04 | $227K |
| Mar 22, 23 | Benjamin KornitzerChief Med. & Quality Officer | SELL | 8.1K | $27.84 | $225K |
| Mar 16, 23 | Veeral DesaiChief Strategy & Dev. Officer | SELL | 60.0K | $26.09 | $1.6M |
| Mar 16, 23 | Benjamin ShakerChief Markets Officer | SELL | 10.6K | $26.08 | $276K |
| Mar 15, 23 | Benjamin KornitzerChief Med. & Quality Officer | SELL | 55.0K | $23.81 | $1.3M |
| Mar 15, 23 | Benjamin ShakerChief Markets Officer | SELL | 35.0K | $23.81 | $833K |
| Mar 15, 23 | John William WulfDirector | SELL | 80.0K | $23.82 | $1.9M |
| Mar 8, 23 | Benjamin KornitzerChief Med. & Quality Officer | SELL | 8.1K | $24.44 | $198K |
| Mar 7, 23 | Benjamin KornitzerChief Med. & Quality Officer | SELL | 8.1K | $24.36 | $197K |
| Feb 15, 23 | Benjamin KornitzerChief Med. & Quality Officer | SELL | 8.1K | $22.98 | $186K |
| Feb 15, 23 | Benjamin ShakerChief Markets Officer | SELL | 28.6K | $23.37 | $667K |
Over the past 12 months, insiders at agilon health, inc. filed 5 open-market purchases worth $351K and 0 sales worth $0 on AGL, which makes them net buyers over the period. The most recent Form 4 was filed on Mar 9, 26.
The largest recent open-market AGL insider purchase in our data was $498K by Steven Sell, CEO & President, filed on Nov 21, 23.
4 different insiders at agilon health, inc. filed open-market SEC Form 4 transactions on AGL over the last 12 months.
InsiderTape plots every AGL insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every agilon health, inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →